154 related articles for article (PubMed ID: 36132198)
1. Perioperative variation in serum FGF-23 level and its correlation with MACCE risk in unprotected left main coronary artery disease patients receiving coronary artery bypassing grafting.
Wang F; Ma R; Wang C
Front Surg; 2022; 9():937342. PubMed ID: 36132198
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting.
Liu H; Yan X; Yu J
J Clin Lab Anal; 2020 Jul; 34(7):e23299. PubMed ID: 32185824
[TBL] [Abstract][Full Text] [Related]
3. Potential of Circulating Proangiogenic MicroRNAs for Predicting Major Adverse Cardiac and Cerebrovascular Events in Unprotected Left Main Coronary Artery Disease Patients Who Underwent Coronary Artery Bypass Grafting.
Shen J; Chang C; Ma J; Feng Q
Cardiology; 2021; 146(3):400-408. PubMed ID: 33730720
[TBL] [Abstract][Full Text] [Related]
4. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.
Wang X; Zhao J; Wang H; Zhao Y; Fu X
Ir J Med Sci; 2021 Feb; 190(1):89-96. PubMed ID: 32529544
[TBL] [Abstract][Full Text] [Related]
5. The effects of a comprehensive rehabilitation and intensive education program on anxiety, depression, quality of life, and major adverse cardiac and cerebrovascular events in unprotected left main coronary artery disease patients who underwent coronary artery bypass grafting.
Ma L; Deng L; Yu H
Ir J Med Sci; 2020 May; 189(2):477-488. PubMed ID: 31758523
[TBL] [Abstract][Full Text] [Related]
6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
7. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
[TBL] [Abstract][Full Text] [Related]
8. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression.
Khan MR; Kayani WT; Ahmad W; Manan M; Hira RS; Hamzeh I; Jneid H; Virani SS; Kleiman N; Lakkis N; Alam M
Clin Cardiol; 2019 Nov; 42(11):1071-1078. PubMed ID: 31486094
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry.
Wańha W; Bil J; Kołodziejczak M; Kowalówka A; Kowalewski M; Hudziak D; Gocoł R; Januszek R; Figatowski T; Milewski M; Tomasiewicz B; Kübler P; Hrymniak B; Desperak P; Kuźma Ł; Milewski K; Góra B; Łoś A; Kulczycki J; Włodarczak A; Skorupski W; Grygier M; Lesiak M; D'Ascenzo F; Andres M; Kleczynski P; Litwinowicz R; Borin A; Smolka G; Reczuch K; Gruchała M; Gil RJ; Jaguszewski M; Bartuś K; Suwalski P; Dobrzycki S; Dudek D; Bartuś S; Ga Sior M; Ochała A; Lansky AJ; Deja M; Legutko J; Kedhi E; Wojakowski W
Front Cardiovasc Med; 2022; 9():849971. PubMed ID: 35615559
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
Liu D; Zhou S; Mao H
J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
Xu L; Hu X; Chen W
J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
[TBL] [Abstract][Full Text] [Related]
13. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].
Pan Y; Mu Y; Zhang Y; He J; Qiu Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1203-1207. PubMed ID: 33198864
[TBL] [Abstract][Full Text] [Related]
15. Perioperative urinary thromboxane metabolites and outcome of coronary artery bypass grafting: a nested case-control study.
Liu H; Xu Z; Sun C; Chen Q; Bao N; Chen W; Zhou Z; Wang X; Zheng Z
BMJ Open; 2018 Aug; 8(8):e021219. PubMed ID: 30166295
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Unprotected Left Main Coronary Artery Disease: Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention.
Song K; Kim MH; Li JX; Kim SJ; Lee KM; Cho YR; Park JS; Park TH; Kim YD; Lee MS
J Invasive Cardiol; 2020 Mar; 32(3):111-116. PubMed ID: 31941834
[TBL] [Abstract][Full Text] [Related]
17. WeChat-based education and rehabilitation program in unprotected left main coronary artery disease patients after coronary artery bypass grafting: an effective approach in reducing anxiety, depression, loss to follow-up, and improving quality of life.
Ma C; Wang B; Zhao X; Fu F; Zheng L; Li G; Guo Q
Braz J Med Biol Res; 2021; 54(4):e10370. PubMed ID: 33624731
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
[TBL] [Abstract][Full Text] [Related]
19. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
[TBL] [Abstract][Full Text] [Related]
20. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
Ahn JM; Roh JH; Kim YH; Park DW; Yun SC; Lee PH; Chang M; Park HW; Lee SW; Lee CW; Park SW; Choo SJ; Chung C; Lee J; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ
J Am Coll Cardiol; 2015 May; 65(20):2198-206. PubMed ID: 25787197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
